Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2012
07/18/2012EP2476669A1 Cyanoisoquinoline compounds and methods of use thereof
07/18/2012EP2476668A1 Aniline compounds
07/18/2012EP2476667A2 Aminoheteroaryl compounds as protein kinase inhibitors
07/18/2012EP2476461A2 Formulations For Cancer Treatment
07/18/2012EP2476438A1 Medicament including antibody composition specifically bound to human cc chemokine receptor 4 (ccr4)
07/18/2012EP2476434A1 Immunogenic composition
07/18/2012EP2476433A1 Immunogenic composition
07/18/2012EP2476431A1 Lyophilised antigen composition
07/18/2012EP2476424A1 Orally administrable tablet for intestinal lavage
07/18/2012EP2476422A1 Pharmaceutical compositon for anti-thrombotic diseases, its preparation method and use
07/18/2012EP2476421A1 Hyaluronic acid based mucoadhesive therapeutic composition for the prevention and treatment of epithelial and mucosal lesions of the human body
07/18/2012EP2476420A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
07/18/2012EP2476419A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
07/18/2012EP2476418A1 Pharmaceutical compound and composition for use in treating type II diabetes comprising rosiglitazone in a specific particle size
07/18/2012EP2476417A1 Method for managing the risk of liver injury in patients receiving treatment with dronedarone
07/18/2012EP2476416A1 Method of Treatment for Inflammatory Bowel Disease
07/18/2012EP2476415A2 Treating bone-related disorders with selective androgen receptor modulators
07/18/2012EP2476414A1 Transdermally absorbable preparation
07/18/2012EP2476409A1 Implant comprising a core and a tube encasing the core
07/18/2012EP2476408A1 External preparation containing pantethine phosphate ester
07/18/2012EP2475779A1 Detecting pax2 for the diagnosis of breast cancer
07/18/2012EP2475769A1 Inhibition of histone acetyltransferases by ctk7a and methods thereof
07/18/2012EP2475676A2 Pregnane derivatives condensed in the 16,17 position with an N-substituted isoxazolidine ring as anti-inflammatory agents
07/18/2012EP2475675A1 Modulation of huntingtin expression
07/18/2012EP2475673A1 Cyclobutan-1,1 -dicarboxylato complexes of platinum with n6-benzyladenine derivatives, method of their preparation and application of these complexes as drugs in antitumour therapy
07/18/2012EP2475668A1 Ether derivatives of bicyclic heteroaryls
07/18/2012EP2475667A1 Inhibitors of jak
07/18/2012EP2475666A2 Gyrase inhibitors
07/18/2012EP2475665A1 [1,2,4]TRIAZOLO [1,5-c]PYRIMIDINE DERIVATIVES AS Hsup90 MODULATORS
07/18/2012EP2475664A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/18/2012EP2475663A2 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities
07/18/2012EP2475662A2 Histamine h3 inverse agonists and antagonists and methods of use thereof
07/18/2012EP2475661A1 Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer
07/18/2012EP2475660A1 Pyrrolo-pyridine derivatives as activators of ampk
07/18/2012EP2475659A1 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
07/18/2012EP2475658A1 2 -aminodihydro [1, 3]thiazines as bace 2 inhibitors for the treatment of diabetes
07/18/2012EP2475657A1 Inhibitors of flaviviridae viruses
07/18/2012EP2475653A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs
07/18/2012EP2475649A1 Indenone derivative and pharmaceutical composition comprising same
07/18/2012EP2475648A1 Ortho substituted pyrimidine compounds as jak inhibitors
07/18/2012EP2475647A1 Androgen receptor antagonists and uses thereof
07/18/2012EP2475645A1 5- (3, 4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as hdl cholesterol raising agents
07/18/2012EP2475644A1 Hsl inhibitors useful in the treatment of diabetes
07/18/2012EP2475643A1 Novel ethane diamine hepcidin antagonists
07/18/2012EP2475430A1 Granulated anthelmintic preparations and delivery systems
07/18/2012EP2475429A1 Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof
07/18/2012EP2475428A1 Heterocylcic derivatives as inhibitors of glutaminyl cyclase
07/18/2012EP2475427A1 Actriib antagonists and dosing and uses thereof
07/18/2012EP2475395A2 High strength seamless alginate capsules
07/18/2012EP2475392A1 Methods for treating irritable bowel syndrome (ibs)
07/18/2012EP2475388A1 Use of il-33 antagonists to treat fibrotic disease
07/18/2012EP2475387A1 Use of vap-1 inhibitors for treating fibrotic conditions
07/18/2012EP2475381A2 Methods for hematopoietic precursor mobilization
07/18/2012EP2475378A2 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
07/18/2012EP2475372A1 Method for the preparation of micro-rna and its therapeutic application
07/18/2012EP2475371A1 Pharmaceutical composition comprising a3 adenosine receptor agonist (ib-meca/cf-101) for treatment of psoriasis
07/18/2012EP2475370A1 Screening method and therapy with agonists of ddah i
07/18/2012EP2475369A1 Use of steroid compounds for inflammatory and autoimmune disorders
07/18/2012EP2475368A1 N-4 ( - ( ( 3- ( 2 -amino-4 pyrimidinyl) -2 -pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer
07/18/2012EP2475367A1 NOVEL INHIBITORS OF STEAROYL-CoA-DESATURASE-1 AND THEIR USES
07/18/2012EP2475366A1 Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs
07/18/2012EP2475365A1 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyri(dyl)-1-[2-[4-pyridyl)ethyl]propyl]propanamide and uses thereof
07/18/2012EP2475364A1 Cancer cell apoptosis
07/18/2012EP2475363A1 Detection of mycobacteria
07/18/2012EP2475362A2 Cancer stem cell-targeted and drug resistant cancer therapy
07/18/2012EP2475361A1 N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation
07/18/2012EP2475360A1 Use of guaifenesin for inhibiting mucin secretion
07/18/2012EP2475359A1 Pharmaceutical formulation containing ribavirin
07/18/2012EP2475357A1 Oral suspension formulations of esclicarbazepine acetate
07/18/2012EP2475352A1 Composition containing ultra-micronized palmitoyl - ethanolamide
07/18/2012EP2475270A1 Composition for prevention against spoilage by moulds and yeasts and uses and products related thereto
07/18/2012EP2475256A1 Hepatitis c virus inhibitors
07/18/2012EP2475254A1 Hepatitis c virus inhibitors
07/18/2012EP2475253A1 Methods for treating malaria, tuberculosis and mac diseases
07/18/2012EP2475252A1 Selective antibacterials for clostridium difficile infections
07/18/2012EP2399993A9 Hypo-immunogenic streptavidin and use thereof
07/18/2012EP2296651B1 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
07/18/2012EP2283022B1 Furo [3, 2-b]pyrr0l-3-0nes as cathepsin s inhibitors
07/18/2012EP2262772B1 Quinoline derivatives as axl kinase inhibitors
07/18/2012EP2254882B1 Use of (3-trifluoromethylsulfonyl)-n-[4-methyl -3-(4-pyridin-3-yl-pyrimidin-2yl-amino)-phenyl]-benzamide against breast cancer, glioma and angiogenesis.
07/18/2012EP2121600B1 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
07/18/2012EP2120923B1 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
07/18/2012EP2101763B1 Pharmaceutical compositions and their methods of use
07/18/2012EP2046723B1 Phenylacetic acid derivatives as cox-2 inhibitors
07/18/2012EP2024340B1 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
07/18/2012EP1999132B1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
07/18/2012EP1982705B1 Pharmaceutical composition containing chenopodium ambrosioides extract and its preparation process and application
07/18/2012EP1978969B1 Hormone combination for alleviation of menstrual cycle dependent mood fluctuations
07/18/2012EP1976489B1 Multiple unit type sustained release oral formulation comprising zaltoprofen and process for the preparation thereof
07/18/2012EP1959990B1 PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions
07/18/2012EP1959957B1 Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis
07/18/2012EP1959948B1 Levodopa prodrug mesylate, compositions thereof, and uses thereof
07/18/2012EP1951046B1 Methods to enhance chemotherapy
07/18/2012EP1937669B9 Novel benzopyran derivatives as potassium channel openers
07/18/2012EP1931346B1 Trazodone composition for once a day administration
07/18/2012EP1901717B1 Orally disintegrating powder comprising cilostazol and mannitol
07/18/2012EP1893649B1 Method for the potentiation of opioid analgesics effects on pain
07/18/2012EP1893039B8 Method for treatment and prevention of respiratory insufficiency
07/18/2012EP1884234B1 Prophylactic or therapeutic agent for corneal and conjunctival disorder
07/18/2012EP1871753B1 Preparation of taxanes from 9-dihydro-13-acetylbaccatin iii
1 ... 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 ... 7860